Therapy-related myeloid leukemia during erlotinib treatment in a non-small cell lung cancer patient: A case report
CONCLUSION: Therapy-related acute myeloid neoplasm (t-MN) is a rare but fatal late complication. Although a patient may be taking EGFR-TKIs, the possibility of t-MN should be considered. Further studies are needed to determine whether EGFR-TKI usage is a predisposing factor for t-MN.PMID:34540979 | PMC:PMC8409203 | DOI:10.12998/wjcc.v9.i24.7205
Source: Clinical Lung Cancer - Category: Cancer & Oncology Authors: So-My Koo Ki-Up Kim Yang-Ki Kim Soo-Taek Uh Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Adenocarcinoma | Alimta | Brain | Brain Cancers | Cancer | Cancer & Oncology | Chemotherapy | Leukemia | Lung Cancer | Neurology | Non-Small Cell Lung Cancer | Study | Tarceva